A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma

Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis

Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study

Consensus Definition of Blood Samples from the Subcategorized Normal Controls in the Korea Biobank Network

Cancer-associated fibroblast-derived secretedphosphoprotein 1 contributes to resistance of hepatocellularcarcinoma to sorafenib and lenvatinib

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma

Efficacy of Co-Medications in Patients with Alcoholic Liver Disease

Independent replication of advanced brain age in mild cognitive impairment and dementia: detection of future cognitive dysfunction

SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma